Dana Farber Partners Cancer Care — Boston, Massachusetts

Dana Farber Partners Cancer Care is a clinical research site located in Boston, Massachusetts, United States.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Dana Farber Partners Cancer Care has participated in 2 clinical trials.

Therapeutic areas: Multiple Myeloma, Carcinoma, Hepatocellular.

Sponsors: Amgen, Genzyme, a Sanofi Company.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Partners Cancer Care?

Dana Farber Partners Cancer Care has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Partners Cancer Care conducted?

Dana Farber Partners Cancer Care has 2 clinical trials on record. Their work covers Multiple Myeloma, Carcinoma, Hepatocellular.

Is Dana Farber Partners Cancer Care accredited by Crixeo Health?

Dana Farber Partners Cancer Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Partners Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.